Introduction
============

Animal intestinal microbiota has a great influence on the health and growth of its host, because they can provide nutrition, improve immune system and modulate gastrointestinal development for host ([@B7]). It was always considered that the intestines of the neonate are sterile and microbiota begins to colonize after delivery ([@B9]). A study reported that the reprogramming of gut microbiota in early life is beneficial for host metabolism later ([@B1]). And the gut flora of neonate affected by cesarean has been association with development of type I diabetes, celiac disease and obesity ([@B6]; [@B28]). Therefore, the establishment of a stable bacterial flora in early life has a connection with metabolism of host.

Amoxicillin (AM) is a broad-spectrum antibiotic that has a bactericidal effect through the inhibition of bacterial cell wall synthesis. Now antibiotics are widely concerned because of their resistance. A previous study showed that early antibiotic intervention could reduce *Escherichia coli* count, and decreased fecal amines concentration ([@B38]). The early antibiotic intervention could affect the microbial colonization over a period of time, and also affect adaptive immune system ([@B30]). Moreover, previous study revealed the early antibiotic intervention increased bacterial fermentation of aromatic amino acids and the expression of proinflammatory cytokines ([@B40]). However, current studies on the effect of antibiotics on neonatal pigs are mainly focused on intestinal development and mucosal immunity, and research on the extraintestinal level is lacking.

Fecal microbiota transplantation (FMT) is a type of intervention therapy in which the functional flora of a healthy body is transplanted into a patient's gastrointestinal tract and the intestinal microflora with normal function are reconstructed. FMT have been treated as an effective treatment for enteritis. Studies showed the significant therapeutic effect of FMT on pseudomembranous enterocolitis ([@B8]; [@B3]) and relapsed *Clostridium difficile* enteritis ([@B11]). What is more, it was reported that intervention of FMT altered the intestinal microbiota structure and improved intestinal morphology and mucosal barrier of neonatal pigs ([@B13]), and could partially convey host gut characteristics from pigs to neonatal mice ([@B7]). While most studies focused on intestinal microflora and intestinal development, information on the roles of FMT in the body metabolism is not well described.

As the metabolic center, the liver is able to reflect the regulating effect of AM and fecal bacterial suspensions on the organism metabolism. In the present study, we hypothesized that the early intervention of AM and fecal bacteria suspension could affect the liver metabolism of new-born piglets, thereby affecting the metabolism of the whole body. Because pigs have a high similarity with man in physiology and other clinical research fields ([@B17]), we choose pig as a model to test, which can better reflect the human status. Thus, the effect of early intervention with antibiotics and fecal bacteria suspensions on liver transcription and metabolome in new-born piglets were investigated in this study through transcriptional analysis and metabolites profile analysis based on gas chromatography-mass spectrometry (GC-MS).

Materials and Methods {#s1}
=====================

Ethics Statement
----------------

The experiment was approved and conducted under the supervision of the Animal Care and Use Committee of Nanjing Agricultural University (Nanjing, Jiangsu province, China). All pigs were raised and maintained on a local commercial farm under the care of the Animal Care and Use Guidelines of Nanjing Agricultural University.

Preparation of Fecal Bacteria Suspension
----------------------------------------

The preparation of FMT was adapted from a previous method ([@B11]). In brief, approximately 50 g fresh feces from a healthy sow that was not treated with antibiotics were mixed with 250 mL sterile 0.9% NaCl solution. The mixture was homogenated and filtered with sterile gauze. The solution was transferred to 10 mL freezing tubes which were filled with CO~2~, and centrifuged at 2000 rpm for 10 min. The supernatant liquid was mixed with 10% sterile glycerol, and stored at −80°C.

Piglet Experiment Design and Sampling
-------------------------------------

Five litters of healthy neonatal pigs (Duroc × Landrace × Yorkshire) from a commercial farm were used as five replicates. Nine piglets in each litter were randomly assigned into the AM, FMT or CO groups, with three piglets in each group. On days 1--6, the piglets in the AM group and CO group were orally administrated once a day with 3 mL AM solution (6.94 mg/mL), and physiological saline (0.9% NaCl), respectively, while the same volume of fecal bacteria suspension (\>10^9^/mL) was offered to the piglets in the FMT group. All pigs had access to breast milk and water *ad libitum* and had no other creep feed during the experiment. At the age of 7 and 21 days, one piglet per group in each litter was randomly selected and slaughtered. Blood sample (10 mL) was collected from the anterior vena cava using heparin tube. The supernatant was collected through centrifuging at 3000 rpm for 15 min, and stored at −28°C for chemical analysis. The liver tissues were collected and stored in liquid nitrogen until transcriptome and metabolome analysis.

Serum Measurement
-----------------

Glucose, cholesterol, triglyceride, low density lipoprotein cholesterol (LDL-C), high density lipoprotein cholesterol (HDL-C), alanine aminotransferase, aspartate aminotransferase, total protein, serum albumin, globulin and alkaline phosphatase in the serum of piglets were measured with an Olympus AU400 Automatic Biochemical Analyzer (Tokyo, Japan) according to the manufacturer's instructions.

RNA Extraction and Sequencing
-----------------------------

In order to reduce the cost of the experiment, three biological replicates were randomly selected from the samples for sequencing. Total RNA was extracted from liver tissue with the RNAiso Plus Total RNA extraction reagent (Takara) following the manufacturer's instructions, and the RNA integrity was detected with Agilent Bioanalyzer 2100 (Agilent Technologies, United States). After purification, mRNA was enriched through removing ribosomal RNA (rRNA) with Ribo-Zero rRNA removal beads, and then RNA was split into fragments using divalent cations. The fragments were converted into the first strand cDNA using SuperScript II reverse transcriptase, and the synthesis of second stand cDNA was executed with DNA polymerase I and RNase H. After terminal repair, addition of base and connection of adapters, the fragments were amplified to create final cDNA libraries by PCR.

The sequencing was performed applying Illumina HiSeq 2500 according to the manufacturer's instructions. About 6 G reads were produced in each sample, and the Q20 value of each sample was higher than 90%. Thus, the samples were qualified for further analysis. The quality results of RNA and sequencing is presented in [Supplementary Table S1](#SM1){ref-type="supplementary-material"}. The raw sequencing reads were submitted to Sequencing Read Archive database under BioProject: [PRJNAS18006](PRJNAS18006).

Sample Preparation for GC-MS Analysis
-------------------------------------

About 100 mg liver tissues were taken in the 2 mL centrifuge tube and added with 1 mL of 80% methanol which pre-cooled at −20°C and five steel balls. The tubes were placed in a high-flux organization grinding apparatus at 70 Hz for 1 min, added with 60 μL of 2-chloro-L-phenylalanine (0.2 mg/mL stock in methanol) and 60 μL of heptadecanoic acid (0.2 mg/mL stock in methanol) as an internal quantitative standard and vortexed for 30 s. The tubes were put into an ultrasonic machine for 30 min at room temperature, and then stew for 30 min on the ice. The tubes were centrifuged for 10 min at 14,000 rpm (4°C), and 0.8 mL of the supernatant was transferred into a new centrifuge tube for blow-drying by vacuum concentration. The samples were added with 60 μL of methoxyamine pyridine solution (15 mg/mL), vortexed for 30 s, and reacted for 120 min at 37°C. About 60 μL of BSTFA reagent (containing 1% chlorotrimethylsilane) was added into the mixture, and then reacted for 90 min at 37°C. The supernatant that was obtained by centrifuging mixture for 10 min at 12,000 rpm (4°C) was transferred to inspect bottle.

GC-MS Analysis
--------------

Each derivative sample (1 μL) was injected by the Agilent 7683 autosampler (Agilent Technologies, Atlanta, GA, United States) into the Agilent 6890 GC system equipped with a fused-silica capillary column (10 m × 0.18 mm i.d.) and a chemically bonded 0.18 μm stationary phase (DB-5; J&W Scientific, Folsom, CA, United States). The carrier gas (helium) passed through column at a speed of 1.0 mL/min. The column temperature is kept at 70°C for two min, and then increased to 310°C at a speed of 30°C/min and kept for two min. The column effluent was guided by a transmission route into the ion source of the mass spectrometer. The temperature of the transmission line and the ion source was 250 and 200°C, respectively. With a rate of 30 spectra/s, the mass spectra were generated in mass range of 50--800 m/z.

Real-Time PCR
-------------

The RNA was extracted from liver tissue with the RNAiso Plus Total RNA extraction reagent (Takara), and then 1 μg RNA of each sample was converted into cDNA with the Reverse Transcriptase Kit (Takara, Japan) following the manufacturer's instructions. Real time PCR was performed on ABI PRISM 7300 sequence detection system (SDS, Foster City, CA, United States) using SYBR Premix DimerEraserTM Kit (Takara, Japan) following the manufacturer's instructions. The mRNA expressions of *cytochrome P450 C42* (*CYP2C42*) ([@B35])*, cytochrome P450 family 1 subfamily A member 2* (*CYP1A2*) ([@B16])*, acetyl-CoA acyltransferase 2* (*ACAA2*) ([@B33]), *tyrosine aminotransferase* (*TAT*)*, argininosuccinate synthase 1* (*ASS1*) and glycine amidinotransferase (*GATM*) were determined to verify the reliability of RNA-seq. The primers for *TAT, ASS1* and *GATM* were designed by Primer-BLAST^[1](#fn01){ref-type="fn"}^. The primer sequences are listed in [Supplementary Table S2](#SM1){ref-type="supplementary-material"}. The results were normalized to the expression level of the β-actin gene ([@B25]), and the fold change (FC) was calculated with the 2^−ΔΔCt^ method.

Data Analysis
-------------

The date of serum measurement and real-time PCR were analyzed by SPSS v. 20 as a completely randomized design, and one litter was regarded as one experiment unit (*n* = 5). The significance of the difference among the three treatments was evaluated by one-way ANOVA. A *P* \< 0.05 was considered significantly different.

The raw data of RNA-seq were converted into clean sequences by removing the sequencing adapter and the low-complexity sequences with Seqtk^[2](#fn02){ref-type="fn"}^. Clean reads were mapped to the reference pig genome (Sus scrofa 10.2) with Hisat2 (version: 2.0.4). Then, the mapped results were quantitatively analyzed by Stringtie (v, 1.3.0) ([@B24]). To normalize the gene expression levels, the RNA-seq reads were converted to fragments per kilobase of exon model per million mapped reads (FPKM) ([@B21]). The differentially expressed genes (DEGs) of the three groups (*n* = 3) was analyzed with the edgeR ([@B27]) and the FC was computed on the basis of the FPKM value. The DEGs with FC value \> 1.5 or \<0.67 and *P* value \< 0.05 were chosen to further analyze.

DAVID Bioinformatics Resources 6.8^[3](#fn03){ref-type="fn"}^ (accessed 4 Dec 2017) was used to conduct the Kyoto Encyclopedia of Genes and Genomes (KEGG) Pathway enrichment analysis and Gene Ontology (GO) enrichment analysis. KEGG database can reflect the pathways involved in differentially genes. The statistical method used was Fisher's exact test, and the false discovery rate (FDR) value was used as the FDR correct method. The enrichment was considered significant when *P* value \< 0.05.

The raw date obtained by GC-MS was converted into netCDF format by Agilent MSD Chemstation ([@B32]). The identification, filtration and alignment of peak was performed with the XCMS program package of R (v3.1.3), and retention time, intensity and mass to charge ratio was acquired. The metabolites were annotated with AMDIS program based on National Institute of Standards and Technology database and Wiley Registry database. The obtained data were normalized to heptadecanoic acid. The online analysis tool of SmartNuclide Corporation^[4](#fn04){ref-type="fn"}^ (accessed 4 Oct 2017) was used to conduct the multivariate analysis of the GC-MS data that was pre-processed and differential metabolite set enrichment analysis. The obtained data was processed by partial least squares discriminant analysis (PLS-DA) ([Supplementary Figure S1](#SM1){ref-type="supplementary-material"}) ([@B34]). To reflect the quality of the model, R2Xcum, R2Ycum and Q2cum were calculated. The metabolites are selected to discriminate among the AM, CO and FMT group in accordance with this threshold of variable importance projection values \> 1 and *P* values \< 0.05. A hypergeometric test was used to conduct metabolite set enrichment analysis which affected by AM and fecal bacteria suspension.

Results
=======

Serum Metabolites
-----------------

On day 7, compared with the CO group, AM increased the concentrations of aspartate aminotransferase and alanine aminotransferase and decreased the concentrations of triglyceride and LCL-C (*P* \< 0.05). FMT increased the concentrations of cholesterol, aspartate aminotransferase and alanine aminotransferase but decreased the levels of triglyceride and LDL-C (*P* \< 0.05). Compared with the AM group, FMT increased the concentration of cholesterol but decreased the level of aspartate aminotransferase (*P* \< 0.05). On day 21, AM increased the concentrations of aspartate aminotransferase and alanine aminotransferase, and decreased the level of cholesterol (*P* \< 0.05). FMT increased the concentration of glucose but decreased the levels of cholesterol, triglyceride and LDL-C (*P* \< 0.05). Compared with the AM group, FMT decreased the levels of LDL-C and aspartate aminotransferase (*P* \< 0.05) ([Supplementary Table S3](#SM1){ref-type="supplementary-material"}).

Metabolomic Analysis of the Liver
---------------------------------

On day 7, AM enriched 7 type of fatty acids and 3 type of amino acids (*P* \< 0.05); FMT enriched 4 type of fatty acids and 3 type of amino acids (*P* \< 0.05). Compared with AM, FMT decreased 3 type of fatty acids (*P* \< 0.05) ([Table 1](#T1){ref-type="table"}). In the further metabolic pathway enrichment analysis, AM affected (FDR \< 0.05) alanine, aspartate and glutamate metabolism, pyruvate metabolism, citrate cycle and arginine biosynthesis ([Figure 1A](#F1){ref-type="fig"}). FMT affected (FDR \< 0.05) alanine, aspartate and glutamate metabolism. No difference in metabolic pathways was found between the AM and FMT groups.

![Enrichment analysis of selected metabolites. The metabolites discriminated among the amoxicillin (AM), fecal microbiota transplantation (FMT) and control (CO) groups on day 7 **(A)** and day 21 **(B)** were used for the metabolite set enrichment analysis based on the online analysis tool of Smart Nuclide Corporation. The rectangle color represents contrast, and the rectangle length is the false discovery rate-adjusted *P*-value.](fphys-10-00171-g001){#F1}

###### 

Differential metabolites in pig livers among the amoxicillin (AM), fecal microbiota transplantation (FMT) and control (CO) groups on day 7.

           Metabolites                       Biological roles                      Metabolic subpathway                          FC^1^   VIP^2^   *P*-value^3^
  -------- --------------------------------- ------------------------------------- --------------------------------------------- ------- -------- --------------
  AM/CO    Glutamine                         Amino acid                            Arginine biosynthesis                         3.34    1.464    0.007
           Asparagine                        Amino acid                            Alanine, aspartate and glutamate metabolism   1.81    1.355    0.016
           Ornithine                         Amino acid                            Ornithine cycle                               1.61    1.417    0.011
           9,12-(Z,Z)-Octadecadienoic acid   Unsaturated fatty acids               Linoleic acid metabolism                      1.38    1.73     \<0.001
           9-(Z)-Octadecenoic acid           Unsaturated fatty acids               Fatty acid biosynthesis                       1.35    1.77     \<0.001
           Arachidonic acid                  Unsaturated fatty acids               Arachidonic acid metabolism                   1.23    1.618    0.003
           9-(Z)-Hexadecenoic acid           Unsaturated fatty acids               Fatty acid biosynthesis                       1.17    1.416    0.012
           Hexadecanoic acid                 Saturated fatty acids                 Fatty acid biosynthesis                       1.24    1.667    0.001
           Octadecanoic acid                 Saturated fatty acids                 Fatty acid biosynthesis                       1.19    1.699    \<0.001
           Heptanoic acid                    Saturated fatty acids                 Others                                        1.15    1.493    0.004
           1-Monohexadecanoylglycerol        lipid                                 Others                                        1.24    1.772    \<0.001
           1-Monooctadecanoylglycerol        lipid                                 Others                                        1.12    1.517    0.009
           Pyruvic acid                      Organates/carboxylates                Pyruvate metabolism                           0.788   1.75     \<0.001
           Malic acid                        Organates/carboxylates                TCA cycle                                     1.19    1.609    0.003
           Fumaric acid                      Organates/carboxylates                TCA cycle                                     1.25    1.625    0.001
           Uridine                           nucleoside                            Pyrimidine metabolism                         0.644   1.469    0.009
           Adenosine-5-monophosphate         nucleoside                            Purine metabolism                             0.505   1.727    \<0.001
           Uridine-5-monophosphate           nucleoside                            Pyrimidine metabolism                         3.93    1.605    0.001
           myo-Inositol-1-phosphate          Carbohydrate                          Inositol phosphate metabolism                 0.877   1.695    \<0.001
           Fructose                          Carbohydrate                          Fructose and mannose metabolism               0.834   1.284    0.026
           Phosphoric acid                   Oxidative phosphorylation relatives   Oxidative phosphorylation                     0.931   1.283    0.024
  FMT/CO   Uridine-5-monophosphate           nucleoside                            Pyrimidine metabolism                         4.86    1.964    \<0.01
           Adenosine-5-monophosphate         nucleoside                            Purine metabolism                             0.277   1.936    \<0.001
           Glutamine                         Amino acid                            Arginine biosynthesis                         4.83    1.69     0.001
           Asparagine                        Amino acid                            Alanine, aspartate and glutamate metabolism   2.29    1.662    0.003
           S-methyl-Cysteine                 Amino acid                            Others                                        1.46    1.317    0.035
           Octadecanoic acid                 Saturated fatty acids                 Fatty acid biosynthesis                       1.27    1.944    \<0.001
           Hexadecanoic acid                 Saturated fatty acids                 Fatty acid biosynthesis                       1.22    1.871    0.001
           9,12-(Z,Z)-Octadecadienoic acid   Unsaturated fatty acids               Linoleic acid metabolism                      1.22    1.612    0.011
           9-(Z)-Octadecenoic acid           Unsaturated fatty acids               Fatty acid biosynthesis                       1.19    1.536    0.018
           1-Monooctadecanoylglycerol        lipid                                 Others                                        1.14    1.33     0.023
           1-Monohexadecanoylglycerol        lipid                                 Others                                        1.1     1.418    0.031
           Xylose                            Carbohydrate                          Amino sugar and nucleotide sugar metabolism   0.877   1.412    0.026
           Galactose                         Carbohydrate                          Galactose metabolism                          0.867   1.336    0.043
           Glucose                           Carbohydrate                          Glycolysis or Gluconeogenesis                 0.867   1.336    0.043
           myo-Inositol-1-Phosphate          Carbohydrates                         Inositol phosphate metabolism                 0.801   1.92     \<0.001
           1,3-Di-tert-butylbenzene          Aromatic compounds                    Others                                        0.915   1.433    0.028
           Phosphoric acid                   Oxidative phosphorylation relatives   Oxidative phosphorylation                     0.908   1.493    0.021
           Pyruvic acid                      Organates/carboxylates                Pyruvate metabolism                           0.828   1.773    0.002
  FMT/AM   Adenosine                         nucleoside                            Purine metabolism                             1.65    1.985    0.001
           Adenosine-5-monophosphate         nucleoside                            Purine metabolism                             0.548   1.975    0.001
           Glyceric acid-3-phosphate         lipid                                 Glycolysis or Gluconeogenesis                 1.32    1.712    0.014
           1-Monohexadecanoylglycerol        lipid                                 Others                                        0.885   1.825    0.006
           myo-Inositol-1-Phosphate          Carbohydrate                          Inositol phosphate metabolism                 0.914   1.691    0.015
           myo-Inositol                      Carbohydrate                          Galactose metabolism                          0.729   1.457    0.049
           9-(Z)-Hexadecenoic acid           Unsaturated fatty acids               Fatty acid biosynthesis                       0.892   1.535    0.040
           9-(Z)-Octadecenoic acid           Unsaturated fatty acids               Fatty acid biosynthesis                       0.88    1.484    0.050
           Oxalic acid                       carboxylates                          Glyoxylate and dicarboxylate metabolism       0.945   1.465    0.046
           1,3-Di-tert-butylbenzene          Aromatic compounds                    Others                                        0.935   1.588    0.022
           Heptanoic acid                    Saturated fatty acids                 Others                                        0.877   1.852    0.004

1

FC = fold change for concentration of metabolites derived from AM, FMT and CO groups.

2

VIP = variable importance projection. This value was got from PLS-DA model with a threshold of 1.

3

The significance P-value was got from Wilcoxon rank sum test with a threshold of 0.05.

On day 21, AM enriched 5 type of fatty acids and 3 type of amino acids (*P* \< 0.05); FMT enriched 5 type of fatty acid and 5 type of amino acid (*P* \< 0.05). Compared with AM, FMT enriched 1 type of fatty acid and 5 type of amino acids (*P* \< 0.05) ([Table 2](#T2){ref-type="table"}). Metabolic pathway enrichment analysis showed that AM affected (FDR \< 0.05) alanine, aspartate and glutamate metabolism ([Figure 1B](#F1){ref-type="fig"}). FMT affected (FDR \< 0.05) the biosynthesis of amino acids and alanine, aspartate and glutamate metabolism. Two metabolic pathways (biosynthesis of amino acids and metabolism of alanine, aspartate and glutamate) were different between the AM and FMT groups (FDR \< 0.05).

###### 

Differential metabolites in pig livers in the AM, FMT, and CO groups on day 21.

           Metabolites                       Biological roles                      Metabolic subpathway                          FC^1^   VIP^2^   *P*-value^3^
  -------- --------------------------------- ------------------------------------- --------------------------------------------- ------- -------- --------------
  AM/CO    Glutamine                         Amino acid                            Arginine biosynthesis                         3.9     2.089    0.001
           S-methyl-Cysteine                 Amino acid                            Others                                        1.25    1.475    0.035
           Asparagine                        Amino acid                            Alanine, aspartate and glutamate metabolism   1.77    2.102    0.001
           Pyroglutamic acid                 Amino acid                            Glutathione metabolism                        0.822   1.883    0.006
           Uridine-5-monophosphate           nucleoside                            Pyrimidine metabolism                         3.09    1.857    0.004
           Adenosine-5-monophosphate         nucleoside                            Purine metabolism                             0.305   1.843    0.009
           Arachidonic acid                  Unsaturated fatty acids               Arachidonic acid metabolism                   1.38    2.044    0.001
           9,12-(Z,Z)-Octadecadienoic acid   Unsaturated fatty acids               Linoleic acid metabolism                      1.3     1.853    0.007
           9-(Z)-Octadecenoic acid           Unsaturated fatty acids               Fatty acid biosynthesis                       1.25    1.739    0.014
           Octadecanoic acid                 Saturated fatty acids                 Fatty acid biosynthesis                       1.24    1.849    0.007
           Hexadecanoic acid                 Saturated fatty acids                 Fatty acid biosynthesis                       1.24    1.7      0.026
           2-Hydroxyglutaric acid            Organates/carboxylates                Others                                        0.789   1.72     0.013
           Pyruvic acid                      Organates/carboxylates                Pyruvate metabolism                           0.727   1.917    0.006
           Sorbitol-6-phosphate              Carbohydrate                          Fructose and mannose metabolism               1.22    2.041    0.001
           Phosphoric acid                   Oxidative phosphorylation relatives   Oxidative phosphorylation                     0.893   1.508    0.048
  FMT/CO   Glutamine                         Amino acid                            Arginine biosynthesis                         8.6     1.865    \<0.001
           Asparagine                        Amino acid                            Alanine, aspartate and glutamate metabolism   2.96    1.947    \<0.001
           Methionine                        Amino acid                            Cysteine and methionine metabolism            1.59    1.566    0.017
           Ornithine                         Amino acid                            Arginine biosynthesis                         1.56    1.429    0.033
           S-methyl-Cysteine                 Amino acid                            Others                                        1.38    1.48     0.019
           Arachidonic acid                  Unsaturated fatty acids               Arachidonic acid metabolism                   1.56    1.737    0.003
           9,12-(Z,Z)-Octadecadienoic acid   Unsaturated fatty acids               Linoleic acid metabolism                      1.49    1.672    0.006
           9-(Z)-Octadecenoic acid           Unsaturated fatty acids               Fatty acid biosynthesis                       1.44    1.594    0.013
           Hexadecanoic acid                 Saturated fatty acids                 Fatty acid biosynthesis                       1.44    1.758    0.003
           Octadecanoic acid                 Saturated fatty acids                 Fatty acid biosynthesis                       1.4     1.917    \<0.001
           1-Monooctadecanoylglycerol        Lipid                                 Others                                        1.33    1.608    0.008
           Glyceric acid-3-phosphate         Lipid                                 Glycolysis or Gluconeogenesis                 0.768   1.375    0.023
           Hypoxanthine                      Nucleoside                            Purine metabolism                             2.04    1.57     0.013
           Adenosine-5-monophosphate         Nucleoside                            Purine metabolism                             0.122   1.679    0.002
           Sorbitol-6-phosphate              Carbohydrate                          Fructose and mannose metabolism               1.24    1.853    \<0.001
           Phosphoric acid                   Oxidative phosphorylation relatives   Oxidative phosphorylation                     0.864   1.407    0.018
           Pyruvic acid                      Organates/carboxylates                Pyruvate metabolism                           0.704   1.613    0.005
  FMT/AM   Glutamine                         Amino acid                            Arginine biosynthesis                         2.2     1.823    0.00426
           Asparagine                        Amino acid                            Alanine, aspartate and glutamate metabolism   1.68    1.92     0.00143
           Glycine                           Amino acid                            Glycine, serine and threonine metabolism      1.49    1.453    0.0348
           Methionine                        Amino acid                            Cysteine and methionine metabolism            1.45    1.635    0.0165
           Alanine                           Amino acid                            Alanine, aspartate and glutamate metabolism   1.28    1.506    0.0312
           Ribose                            Carbohydrate                          Pentose phosphate pathway                     1.17    1.539    0.0287
           Maltose                           Carbohydrate                          Starch and sucrose metabolism                 2.07    1.721    0.00998
           Galactose                         Carbohydrate                          Galactose metabolism                          0.94    1.599    0.023
           Glucose                           Carbohydrate                          Glycolysis or Gluconeogenesis                 0.94    1.599    0.023
           Adenosine                         nucleoside                            Purine metabolism                             0.666   1.55     0.028
           Uridine-5-monophosphate           Nucleoside                            Pyrimidine metabolism                         0.662   1.674    0.0125
           Adenosine-5-monophosphate         Nucleoside                            Purine metabolism                             0.402   1.654    0.0183
           Octadecanoic acid                 Saturated fatty acids                 Fatty acid biosynthesis                       1.13    1.518    0.0321
           1-Monooctadecanoylglycerol        Lipid                                 Others                                        1.17    1.548    0.0285

1

FC = fold change for concentration of metabolites derived from AM, FMT and CO groups.

2

VIP = variable importance projection. This value was got from PLS-DA model with a threshold of 1.

3

The significance P-value was got from Wilcoxon rank sum test with a threshold of 0.05.

Gene Expression Profile in the Liver
------------------------------------

On day 7, a total of 632 DEGs (*P* \< 0.05) were found between the AM and CO groups, 252 DEGs (*P* \< 0.05) between the FMT and CO groups and 261 DEGs (*P* \< 0.05) between the AM and FMT groups ([Figure 2](#F2){ref-type="fig"}). Among the DEGs, genes related to fatty acid metabolism, including *CYP2C42*, were upregulated, and *CYP1A2*, *arachidonate 12-lipoxygenase* (*ALOX12*) and *ACAA2* were downregulated (*P* \< 0.05) by AM. FMT upregulated (*P \< 0.05*) *CYP2C42* and downregulated (*P \< 0.05*) *arachidonate 15-lipoxygenase* (*ALOX15*) and *CYP1A2* ([Table 3](#T3){ref-type="table"}). The amino acid metabolism related genes including *glutamic--pyruvic transaminase 2* (*GPT2*)*, arginase 1* (*ARG1*)*, TAT, ASS1, amine oxidase, copper containing 2* (*AOC2*)*, 5′-aminolevulinate synthase 2* (*ALAS2*)*, GATM and ornithine aminotransferase* (*OAT*), were downregulated by AM (*P* \< 0.05), and FMT downregulated *GPT2* ([Table 4](#T4){ref-type="table"}). On day 21, a total of 164 DEGs (*P* \< 0.05) were found between AM and CO, 168 DEGs (*P* \< 0.05) between FMT and CO and 111 DEGs (*P* \< 0.05) between AM and FMT ([Figure 2](#F2){ref-type="fig"}). Among the DEGs, *ALOX15* was upregulated (*P* \< 0.05) by AM ([Table 3](#T3){ref-type="table"}), and *ALAS2* was upregulated by AM and FMT ([Table 4](#T4){ref-type="table"}).

![Number of the total differentially expressed genes (DEGs) as well as the up- and downregulated genes in the livers of pigs among the AM, FMT and CO groups on days 7 and 21.](fphys-10-00171-g002){#F2}

###### 

Expression of fatty acid metabolism-related genes in the liver of piglets in the AM, FMT, and CO groups on days 7 and 21^1^.

  Gene      Day 7          Day 21                                                      
  --------- -------------- -------------- -------------- -------------- -------------- --------------
  CYP2C42   1.656(0.042)   1.955(0.000)   0.847(0.361)   1.174(0.529)   1.092(0.901)   1.075(0.702)
  ALOX15    0.933(0.723)   0.330(0.001)   2.829(0.010)   3.564(0.025)   2.552(0.193)   1.397(0.395)
  CYP1A2    0.457(0.005)   0.513(0.019)   0.890(0.297)   1.081(0.722)   1.075(0.835)   1.006(0.962)
  ALOX12    0.603(0.002)   0.788(0.058)   0.765(0.124)   0.923(0.616)   0.952(0.624)   0.970(1)
  ACAA2     0.600(0.007)   0.739(0.104)   0.813(0.105)   0.810(0.436)   0.926(0.514)   0.874(0.798)

1

Date were presented as fold change (P value); "0.000" means less than 0.001; The gene expressions were considered to be significantly altered when Fold change \> 1.5 or \< 0.67, P \< 0.05; CYP2C42: cytochrome P450 C42; ALOX15: arachidonate 15-lipoxygenase; CYP1A2: cytochrome P450 family 1 subfamily A member 2; ALOX12: arachidonate 12-lipoxygenase; ACAA2: acetyl-CoA acyltransferase 2.

###### 

Expression of amino acid metabolism-related genes in the liver of piglets in the AM, FMT, and CO groups on days 7 and 21^1^.

  Gene    Day 7          Day 21                                                      
  ------- -------------- -------------- -------------- -------------- -------------- --------------
  GPT2    0.406(0.000)   0.566(0.007)   0.717(0.076)   1.200(0.389)   1.432(0.153)   0.838(0.494)
  ARG1    0.541(0.000)   0.881(0.306)   0.614(0.005)   1.127(0.587)   1.162(0.613)   0.970(0.921)
  TAT     0.599(0.003)   0.713(0.040)   0.840(0.242)   1.222(0.280)   0.905(0.422)   1.350(0.091)
  ASS1    0.659(0.020)   0.771(0.165)   0.855(0.330)   1.051(0.859)   1.188(0.583)   0.884(0.707)
  AOC2    0.585(0.004)   0.879(0.315)   0.665(0.119)   1.369(0.238)   1.279(0.357)   1.071(0.663)
  ALAS2   0.609(0.017)   0.726(0.127)   0.838(0.326)   1.509(0.005)   1.895(0.040)   0.796(0.593)
  GATM    0.618(0.035)   0.710(0.016)   0.870(0.488)   0.948(0.817)   0.669(0.105)   1.418(0.073)
  OAT     0.455(0.000)   0.730(0.075)   0.624(0.016)   0.991(0.812)   1.160(0.666)   0.854(0.487)

1

Date were presented as fold change (P value); "0.000" means less than 0.001; The gene expressions were considered to be significantly altered when Fold change \> 1.5 or \< 0.67, P \< 0.05; GPT2: glutamic--pyruvic transaminase 2; ARG1: arginase 1; TAT: tyrosine aminotransferase; ASS1: argininosuccinate synthase 1; AOC2: amine oxidase, copper containing 2; ALAS2: 5′-aminolevulinate synthase 2; GATM: glycine amidinotransferase; OAT: ornithine aminotransferase.

The result of the GO enrichment analysis is presented in [Supplementary Figure S2](#SM1){ref-type="supplementary-material"}. On day 7, 24 terms were significantly varied. Most of terms were related to the metabolic process, genetic expression, immune process and cell process. Among them, AM significantly affected 19 of the terms ([Supplementary Figure S2A](#SM1){ref-type="supplementary-material"}). On day 21, a total of 23 terms were significantly varied ([Supplementary Figure S2B](#SM1){ref-type="supplementary-material"}). Most of the terms were related to the metabolic process, immune process, cell process, respond to stimulus and genetic expression.

Kyoto Encyclopedia of Genes and Genomes enrichment analysis showed that on day 7, arachidonic acid metabolism and steroid hormone biosynthesis were significantly affected by AM and FMT treatment ([Figure 3A](#F3){ref-type="fig"}). AM significantly affected the biosynthesis of antibiotics, arginine biosynthesis, biosynthesis of amino acids and arginine and proline metabolism and FMT significantly affected the retinol metabolism, linoleic acid metabolism and tyrosine metabolism. Compared with FMT, AM significantly affected axon guidance and Jak-STAT signaling pathway. On day 21, steroid hormone biosynthesis were significantly affected by AM and FMT. Only FMT significantly affected the ovarian steroidogenesis and relevant metabolism of cytochrome P450. Compared with FMT, AM significantly affected the prolactin signaling pathway and peroxisome proliferator-activated receptor (PPAR) signaling pathway ([Figure 3B](#F3){ref-type="fig"}).

![Kyoto Encyclopedia of Genes and Genomes pathway analysis of the DEGs in the livers among the AM, FMT and CO groups on day 7 **(A)** and day 21 **(B)**.](fphys-10-00171-g003){#F3}

Validation of the RNA-Seq Results by Quantitative PCR (qPCR)
------------------------------------------------------------

To validate the gene expression profile from RNA-seq, we validated six genes (*CYP2C42, CYP1A2, ACAA2, TAT, ASS1 and GATM*) with qPCR. The qPCR dates of the genes are displayed in [Supplementary Table S4](#SM1){ref-type="supplementary-material"}. The result showed that the expression trend of these genes was the same as that detected by RNA-seq ([Figure 4](#F4){ref-type="fig"}).

![The qPCR validation of the RNA-seq. The results are displayed as the values of fold changes in the CO group on day 7 **(A)** and day 21 **(B)**, and the qPCR data are presented as the means ± SEM (*n* = 5). Values with different lowercase letter superscripts indicate a significant difference (*P* \< 0.05), and those with the same letter superscripts indicate no significant difference (*P* \> 0.05). CO: control; AM: amoxicillin; FMT: fecal microbiota transplantation. CYP2C42: cytochrome P450 C42; CYP1A2: cytochrome P450 family 1 subfamily A member 2; ACAA2: acetyl-CoA acyltransferase 2; TAT: tyrosine aminotransferase; ASS1: argininosuccinate synthase 1; GATM: glycine amidinotransferase.](fphys-10-00171-g004){#F4}

Discussion
==========

Antibiotics are the frontline therapy against microbial infectious diseases, but most antibiotics can cause side effects in humans ([@B31]). A previous study reported that amoxicillin--clavulanic acid could induce hepatitis characterized by elevated aminotransferase levels when people use amoxicillin--clavulanic acid for the treatment of chronic rhinosinusitis ([@B5]). In the current study, we found that piglets treated with AM had significantly elevated levels of aspartate aminotransferase and alanine aminotransferase compared with those in the CO group on days 7 and 21. Pefloxacin and AM significantly increased the concentration of cholesterol, triglyceride, HDL-C and LDL-C in the plasma of rats ([@B29]). Nonetheless, in the current study, the levels of triglyceride and LDL-C in the piglets treated with AM were significantly decreased on day 7, and the cholesterol level was also significantly decreased by AM on day 21. The differences in the effect of AM treatment could have resulted from the differences in species, age and environmental conditions of animals, as well as the dose of antibiotics used in the study. Interestingly, the FMT group had the same effect on triglyceride, LDL-C and cholesterol in plasma.

A previous study reported that subtherapeutic antibiotic treatment (penicillin VK, vancomycin, penicillin VK plus vancomycin and chlortetracycline) could significantly increase fat mass in mice and alter the fatty acid metabolism and lipid metabolic processes of the liver ([@B4]). In our study, we investigated the effects of antibiotics on the host hepatic transcriptome and metabolome in the pigs. AM significantly affected the KEGG of arachidonic acid metabolism on day 7, and the differential metabolite analysis revealed that AM increased seven types of fatty acids on day 7. Moreover, AM increased five types of fatty acids on day 21. Similarly, FMT significantly altered the linoleic acid and arachidonic acid metabolism in the KEGG term. It also increased four types of fatty acids on day 7 and five types of fatty acids on day 21. This phenomenon might suggest that FMT had a similar effect on the fatty acid metabolism to antibiotics.

Arachidonate 15-lipoxygenase encoded by *ALOX15* is capable of oxidizing polyenoic fatty acids, including arachidonic acid and linoleic acid ([@B2]; [@B36]; [@B20]; [@B15]). In our study, *ALOX15* was downregulated by FMT on day 7. Arachidonate 12-lipoxygenase encoded by *ALOX12* catalyzed the transformation of arachidonic acid into 12(S)-hydroperoxyeicosatetraenoic acid by oxygenating its 12-position ([@B19]). We found that *ALOX12* was downregulated by AM on day 7. Meanwhile, arachidonic acid was enriched by both AM and FMT treatments on days 7 and 21, and arachidonic acid metabolism were significantly affected by AM and FMT on day 7. This result suggests that both FMT and antibiotic can reduce oxidative catabolism of arachidonic acid.

The medium chain 3-ketoacyl-CoA thiolase encoded by *ACAA2* is essential to mitochondrial fatty acid β-oxidation ([@B12]). *ACAA2* was downregulated by AM, and tended to be downregulated by FMT on day 7. This finding suggested that AM and FMT decreased fatty acid oxidation, such as arachidonic acid oxidation and linoleic acid oxidation. *CYP1A2* has been reported to catalyze the oxidative metabolism of polyunsaturated fatty acids, such as linoleic acid ([@B37]). However, *CYP1A2* was downregulated by AM and FMT in our study. And the differential metabolite analysis showed that multiple fatty acids in AM and FMT groups were significantly enriched. Thus, these results indicate that AM and FMT can increase the hepatic level of fatty acids by decreasing the fatty acid oxidation and catabolism.

Furthermore, previous studies revealed that antibiotics increased the serum concentration of most amino acids and decreased most amino acids of the small intestine, and that they supplemented the upregulation of the mRNA expression levels for key amino acid receptors and transporters of the small intestine ([@B26]; [@B22]; [@B39]). These findings suggested that antibiotics promoted amino acid absorption and significantly affected the metabolomics markers of amino acid metabolism in piglets ([@B14]; [@B22]; [@B39]). In our study, the KEGG analysis showed that AM significantly affected glycine, serine and threonine metabolism, arginine biosynthesis and arginine and proline metabolism on day 7. In the differential metabolic pathway analysis, AM significantly affected arginine biosynthesis and alanine, aspartate and glutamate metabolism on day 7 and alanine, aspartate and glutamate metabolism on day 21. Moreover, AM significantly increased three types of amino acids in the liver on day 7 and significantly altered four types of amino acids in the liver on day 21. Similarly, FMT had a significant effect on tyrosine metabolism. However, in metabolome analysis, FMT significantly altered the alanine, aspartate and glutamate metabolism on day 7 as well as the biosynthesis of amino acids and the metabolism of alanine, aspartate and glutamate on day 21. In addition, FMT significantly increased three type of amino acids on day 7 and five type of amino acids on day 21.

Glutamate pyruvate transaminase 2 encoded by *GPT2* catalyzes the reversible transference of an amino group from glutamate to pyruvate, yielding alanine and α-ketoglutarate ([@B23]). In this study, *GPT2* was downregulated by AM and FMT on day 7, and glutamine was enriched by AM and FMT on day 7 and 21. Meanwhile, pyruvic acid was decreased by AM and FMT. This phenomenon indicates that both AM and FMT may reduce transamination of glutamate to synthesize alanine and improve the alanine, aspartate and glutamate metabolism. Interestingly, AM also decreased the level of alanine in the liver on day 21 in comparison with the FMT treatment, which suggests that antibiotics have more significant effect on reducing alanine biosynthesis than FMT.

Argininosuccinate synthetase encoded by *ASS1* catalyzed the transformation of aspartate into arginine, which is described as the penultimate step of arginine biosynthesis ([@B10]; [@B18]), and *ASS1* was downregulated by AM in the present study. Asparagine in liver was enriched by AM and FMT, and the arginine biosynthesis pathway was significantly altered by AM on day 7. These findings suggest that AM can decrease arginine biosynthesis by reducing transformation of aspartate, and also increase the alanine, aspartate and glutamate metabolism.

The other genes related to amino acid metabolism, such as *ARG1*, *TAT, AOC2, ALAS2, GATM* and *OAT* were downregulated by AM on day 7. Compared with the FMT treatment, AM significantly affected the metabolic pathway of the biosynthesis of amino acids and the metabolism of alanine, aspartate and glutamate on day 21. This finding suggests that the impact of early intervention with antibiotics on decreasing the amino acid metabolism can last until day 21.

Conclusion
==========

In summary, our study investigated the transcriptome and metabolome responses induced by the short-term oral administration of AM and FMT in the early life of piglets. We found that both FMT and antibiotics could reduce fatty acid oxidative catabolism and amino acid biosynthesis in the liver, and that antibiotics had a more significant effect on reducing alanine biosynthesis and amino acid metabolism than FMT. Our finding provides a reference for regulation host metabolism through early intervention in animal production and even human health. However, more studies are needed for further understanding the impact and regulating mechanism of early intervention with AM and FMT on host metabolism in the later life.
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